"Measles Vaccine in Bangladesh Produces More Than Anticipated Mortality Decline"

Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

 

------------------------------------------------------------

 

April 23, 2003

 

INTERNATIONAL IMMUNIZATION NEWS

 

"Measles Vaccine in Bangladesh Produces More Than Anticipated Mortality Decline"

Reuters Health Information Services (www.reutershealth.com) (04/21/03); Vidyashankar, C.

 

Researchers studying measles vaccinations in Bangladesh say that the process of vaccinating children against the illness has resulted in a reduction of child mortality greater than can be explained simply through the process of measles prevention.  According to Dr. Peter Aaby of the Statens Serum Institut in Copenhagen, Denmark, and colleagues, surveillance data from 1982 to 1985 in Matlab, Bangladesh, shows that mortality among children in the vaccinated population was 49 percent below the mortality rate in areas that had not received measles vaccinations--and after taking into account measles-related deaths, the mortality rate was still 43 percent lower.  Published in the International Journal of Epidemiology, the findings show that the difference in risk of mortality was most striking during the first six months after vaccination, when mortality was 74 percent lower than in unvaccinated regions, with benefits extending as long as two years.  After 1986, when all Bangladesh regions received measles vaccinations, there was no significant difference among various populations in terms of mortality.

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.